Rapidly growing mycobacteria in Singapore, 2006–2011

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Migrant health—a cause for concern?

Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Refugee crisis and re-emergence of forgotten infections in Europe

Is antimicrobial stewardship cost-effective

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

P. Nordmann, L. Poirel Clinical Microbiology and Infection

A.E. Muller, U. Theuretzbacher, J.W. Mouton

E. Cambau, M. Drancourt Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Clinical Microbiology and Infection

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

Vector control: a cornerstone in the malaria elimination campaign

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

Non-tuberculous mycobacterial keratitis

Isospora belli Clinical Microbiology and Infection

Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination M.-R. Lee,

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008 C.-K. Tan, C.-C.

G. Pappas Clinical Microbiology and Infection

Acute schistosomiasis, a diagnostic and therapeutic challenge

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Previously unknown species of Aspergillus

The practice of travel medicine in Europe

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Abstracts cont. Clinical Microbiology and Infection

Vaccinations against respiratory tract infections at Hajj

Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteraemia and literature.

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

Antimicrobial drug development – the past, the present, and the future

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

An after-hours clinical liaison blood culture service—is it worth it?

Examination of specimens for mycobacteria in clinical laboratories in 21 countries: a 10- year review of the UK National Quality Assessment Scheme for.

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

In-vitro evaluation of the adhesion to polypropylene sutures of non-pigmented, rapidly growing mycobacteria N. Zamora, J. Esteban, T.J. Kinnari, A. Celdrán,

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

Great oaks from little acorns grow—21 years of CMI

Impact of antibiotic restrictions: the patient's perspective

J. Esteban, A. Molleja, F. Cabria, M. Soledad Jimenez

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Rapidly growing mycobacteria in Singapore, 2006–2011 S.S. Tang, D.C. Lye, R. Jureen, L.-H. Sng, L.Y. Hsu Clinical Microbiology and Infection Volume 21, Issue 3, Pages 236-241 (March 2015) DOI: 10.1016/j.cmi.2014.10.018 Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

FIG. 1 Species distribution of rapidly growing mycobacteria by year from 2006 to 2011. Clinical Microbiology and Infection 2015 21, 236-241DOI: (10.1016/j.cmi.2014.10.018) Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

FIG. 2 Antimicrobial susceptibilities of Mycobacterium abscessus and Mycobacterium fortuitum group. Clinical Microbiology and Infection 2015 21, 236-241DOI: (10.1016/j.cmi.2014.10.018) Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

FIG. 3 Secular trend of antimicrobial susceptibilities of (a) linezolid against Mycobacterium abscessus; (b) imipenem against Mycobacterium fortuitum group; and (c) clarithromycin against M. fortuitum group. Clinical Microbiology and Infection 2015 21, 236-241DOI: (10.1016/j.cmi.2014.10.018) Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions